Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Short Interest Update

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totaling 4,712 shares, a drop of 82.6% from the November 30th total of 27,049 shares. Based on an average daily volume of 13,049 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily volume of 13,049 shares, the days-to-cover ratio is presently 0.4 days.

Santen Pharmaceutical Stock Performance

OTCMKTS:SNPHY traded up $0.21 during mid-day trading on Friday, hitting $10.58. 11,266 shares of the company traded hands, compared to its average volume of 8,974. The stock’s fifty day moving average price is $10.13 and its 200-day moving average price is $10.73. Santen Pharmaceutical has a one year low of $8.65 and a one year high of $12.04.

About Santen Pharmaceutical

Santen Pharmaceutical Co, Ltd. is a Japan‐based specialty pharmaceutical company focused exclusively on ophthalmology. Headquartered in Osaka, Santen engages in the research, development, manufacture and marketing of prescription and over‐the‐counter products for the diagnosis and treatment of eye diseases. Its core product portfolio includes therapies for glaucoma, dry eye, retinal disorders, uveitis and post‐operative care, as well as surgical equipment and diagnostic agents designed to support comprehensive eye care.

With roots tracing back to the late 19th century, Santen has grown from a domestic manufacturer to a global ophthalmic specialist.